Cardiovascular pharmacogenomics and individualized drug therapy

被引：50
|
作者：
Pereira, Naveen L. [1 ]
Weinshilboum, Richard M. [2 ]
机构：
[1] Mayo Clin, Div Cardiovasc Dis, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin, Div Clin Pharmacol, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
来源：
NATURE REVIEWS CARDIOLOGY | 2009年 / 6卷 / 10期
关键词：
CONGESTIVE-HEART-FAILURE; CYP2D LOCUS; WARFARIN; POLYMORPHISMS; ASSOCIATION; METABOLISM; GENE; IDENTIFICATION; DEBRISOQUINE; INFORMATION;
D O I：
10.1038/nrcardio.2009.154
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The goal of individualized drug therapy requires physicians to be able to accurately predict an individual's response to a drug. Both genetic and environmental factors are known to influence drug response. 'Pharmacogenetics' is the study of the role of inheritance in variation in drug response phenotypes. Pharmacogenetics is now moving genome-wide to become 'pharmacogenomics', resulting in the recognition of novel biomarkers for individual variation in drug response. This article reviews the development, promise and challenges facing pharmacogenomics, using examples of drugs used to treat or prevent cardiovascular disease.
引用
收藏
页码：632 / 638
页数：7
相关论文
共 50 条
  • [21] Pharmacogenomics in Childhood Rheumatic Disorders: A Foundation for Future Individualized Therapy
    Polk, Brooke I.
    Becker, Mara L.
    [J]. DISCOVERY MEDICINE, 2013, 16 (90) : 267 - 275
  • [22] Pharmacogenomics in colorectal cancer: The first step for individualized-therapy
    Eva Bandrés
    Ruth Zárate
    Natalia Ramirez
    Ana Abajo
    Nerea Bitarte
    Jesus García-Foncillas
    [J]. World Journal of Gastroenterology, 2007, (44) : 5888 - 5901
  • [23] Pharmacogenomics in colorectal cancer:: The first step for individualized-therapy
    Bandres, Eva
    Zarate, Ruth
    Ramirez, Natalia
    Abajo, Ana
    Bitarte, Nerea
    Garcia-Foncillas, Jesus
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (44) : 5888 - 5901
  • [24] Pharmacogenomics to Revive Drug Development in Cardiovascular Disease
    Dube, Marie-Pierre
    de Denus, Simon
    Tardif, Jean-Claude
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2016, 30 (01) : 59 - 64
  • [25] Pharmacogenomics to Revive Drug Development in Cardiovascular Disease
    Marie-Pierre Dubé
    Simon de Denus
    Jean-Claude Tardif
    [J]. Cardiovascular Drugs and Therapy, 2016, 30 : 59 - 64
  • [26] Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie ahead (vol 500, pg 267, 2004)
    Nebert, DW
    Vesell, ES
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 506 (03) : 297 - 297
  • [27] UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual care
    Rakhra-Burris, Tejinder K.
    Auman, J. Todd
    Deverka, Patricia
    Dressler, Lynn G.
    Evans, James P.
    Goldberg, Richard M.
    Havener, Tammy M.
    Hoskins, Janelle M.
    Jonas, Daniel E.
    Long, Kevin M.
    Motsinger-Reif, Alison A.
    Irvin, William J.
    Richards, Kristy L.
    Roederer, Mary W.
    Valgus, John M.
    van Riper, Marcia
    Vernon, John A.
    Zamboni, William C.
    Wagner, Michael J.
    Walko, Christine M.
    Weck, Karen E.
    Wiltshire, Tim
    McLeod, Howard L.
    [J]. PHARMACOGENOMICS, 2010, 11 (01) : 13 - 21
  • [28] Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
    Ma, Qiang
    Lu, Anthony Y. H.
    [J]. PHARMACOLOGICAL REVIEWS, 2011, 63 (02) : 437 - 459
  • [29] PHARMACOGENOMICS-GUIDED DRUG THERAPY FOR HYPERTENSION
    Sun, Ningling
    Shu, Chang
    Zhang, Yanwei
    Hu, Songnian
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1716 - 1716
  • [30] PHARMACOGENOMICS-A GENETIC APPROACH OF DRUG THERAPY
    Kumar, R. Santosh
    Kiran, P. Sesha Sai
    Dhibar, Sandrila
    Sunayana, N.
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (05): : 4063 - 4071
12345